Dorman Announces the Appointment of Lisa Bachmann to Its Board of Directors
COLMAR, Pa., Sept. 28, 2020 (GLOBE NEWSWIRE) — Dorman Products, Inc. (NASDAQ:DORM) today announced that Lisa Bachmann has been appointed […]
Rubius Therapeutics Appoints Jose Carmona as Chief Financial Officer
CAMBRIDGE, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red […]
Plexus Announces Manufacturing Award for the Quidel Sofia®2 Fluorescent Immunoassay Analyzer
NEENAH, Wis., Sept. 28, 2020 (GLOBE NEWSWIRE) — Plexus (NASDAQ: PLXS) announced today its partnership with Quidel Corporation (“Quidel”) in […]
First Mid Bancshares, Inc. and LINCO Bancshares, Inc. to Merge
MATTOON, Ill. and COLUMBIA, Mo., Sept. 28, 2020 (GLOBE NEWSWIRE) — First Mid Bancshares, Inc. (“First Mid”) (NASDAQ: FMBH) and […]
Intellia Therapeutics to Present at Chardan’s Virtual 4th Annual Genetic Medicines Conference
CAMBRIDGE, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing […]
ManTech Schedules Third Quarter Fiscal Year 2020 Earnings Release and Conference Call for November 5, 2020
HERNDON, Va., Sept. 28, 2020 (GLOBE NEWSWIRE) — ManTech International Corporation (Nasdaq: MANT) will issue its third quarter fiscal year […]
NeuBase Therapeutics to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference on Monday, October 5th
PITTSBURGH, Sept. 28, 2020 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating […]
Landmark Infrastructure Partners LP Announces Completion of $52.5 Million Digital Infrastructure Acquisition
EL SEGUNDO, Calif., Sept. 28, 2020 (GLOBE NEWSWIRE) — Landmark Infrastructure Partners LP (the “Partnership” or “Landmark”) (NASDAQ: LMRK) announced […]
Arbutus to Participate in Virtual Fireside Chat at Chardan’s 4th Annual Genetic Medicines Conference
WARMINSTER, Pa., Sept. 28, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on […]
SuRo Capital Corp. Declares $0.25 Per Share Dividend
SAN FRANCISCO, Sept. 28, 2020 (GLOBE NEWSWIRE) — SuRo Capital Corp. (“SuRo Capital” or the “Company”) (Nasdaq:SSSS) today announced the […]
